X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://investor.lilly.com/news-releases/news-release-details/tirzepatide-reduced-sleep-apnea-severity-nearly-two-thirds
https://www.prnewswire.com/news-releases/tirzepatide-reduced-sleep-apnea-severity-by-up-to-nearly-two-thirds-in-adults-with-obstructive-sleep-apnea-osa-and-obesity-302118929.html
https://www.reuters.com/business/healthcare-pharmaceuticals/most-doses-lillys-mounjaro-zepbound-limited-availability-us-fda-says-2024-04-17/
https://endpts.com/eli-lilly-loses-case-against-florida-compounding-pharmacy/
https://www.reuters.com/business/healthcare-pharmaceuticals/some-doses-lillys-zepbound-short-supply-through-april-end-us-fda-says-2024-04-03/
https://www.fiercepharma.com/pharma/unprecedented-demand-eli-lillys-zepbound-sparks-nationwide-supply-constraints
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-weight-loss-drug-zepbound-new-us-prescriptions-surpass-wegovy-first-time-2024-03-15/
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-partners-with-amazon-deliver-zepbound-other-drugs-2024-03-13/
https://endpts.com/cbo-hints-that-medicare-may-soon-cover-obesity-drugs-for-their-cardiovascular-benefits/
https://www.fiercepharma.com/pharma/eli-lilly-deeply-concerned-over-fake-and-compounded-versions-its-mounjaro-zepbound
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-ceo-says-its-obesity-drug-could-enter-india-early-2025-2024-02-28/
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-review-lillys-mounjaro-multi-dose-pen-2024-02-19/
https://www.reuters.com/business/healthcare-pharmaceuticals/britain-sees-launch-lillys-weight-loss-drug-mounjaro-2024-02-14/
https://endpts.com/fda-goes-after-websites-marketing-unapproved-semaglutide-tirzepatide/
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/fda-warns-online-vendors-selling-misbranded-weight-loss-diabetes-drugs/107680280#:~:text=New%20Delhi%3A%20The%20U.S.%20Food,diabetes%20and%20weight%2Dloss%20drugs.
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-sees-2024-profit-above-estimates-strong-demand-weight-loss-drug-2024-02-06/
https://www.fiercepharma.com/pharma/eli-lilly-mounts-clinical-and-commercial-case-tirzepatide-mounjaro-zepbound-come-their-own
https://endpts.com/lillys-weight-loss-drug-zepbound-generates-175-8m-in-q4-as-mounjaro-sales-also-rise/
https://www.reuters.com/business/healthcare-pharmaceuticals/fda-website-shows-limited-availability-some-doses-lillys-mounjaro-2024-02-05/
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-talks-with-germany-over-weight-loss-drug-coverage-spiegel-2024-01-29/
https://www.reuters.com/business/healthcare-pharmaceuticals/rise-reports-fake-weight-loss-drugs-linked-shortage-real-thing-who-says-2024-01-29/
https://www.reuters.com/business/healthcare-pharmaceuticals/lillys-mounjaro-dose-limited-availability-us-through-next-month-2024-01-24/
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-exec-says-supply-reimbursement-are-factors-new-mounjaro-launches-2024-01-16/
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-says-no-evidence-yet-linking-weight-loss-drugs-suicidal-thoughts-2024-01-11/
https://endpts.com/lilly-disavows-use-of-mounjaro-zepbound-for-cosmetic-weight-loss/
https://www.fiercebiotech.com/biotech/lilly-tames-fauna-go-prowl-obesity-targets-494m-deal
https://endpts.com/how-eli-lilly-is-rolling-out-zepbound-the-weight-loss-drug-that-can-sell-itself/
https://endpts.com/digital-health-startup-ro-now-prescribes-recently-approved-weight-loss-drug-zepbound/
https://www.reuters.com/business/healthcare-pharmaceuticals/patients-eli-lillys-drug-regain-weight-after-stopping-treatment-jama-study-2023-12-11/
https://www.prnewswire.com/news-releases/zepbound-tirzepatide-is-now-available-in-us-pharmacies-for-adults-living-with-obesity-302006027.html
https://www.reuters.com/business/healthcare-pharmaceuticals/lillys-mounjaro-leads-more-faster-weight-loss-than-novo-obesity-drug-data-2023-11-27/
https://endpts.com/us-international-trade-commission-takes-on-eli-lillys-tirzepatide-case/
https://www.fiercepharma.com/pharma/novo-nordisk-fights-back-lilly-wegovy-combo-trial-against-zepbound-obesity
https://www.prnewswire.com/news-releases/jrnys-wellness-becomes-the-first-weight-loss-platform-to-offer-newly-fda-approved-zepbound-for-weight-loss-301989646.html
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-backs-eli-lillys-mounjaro-weight-management-2023-11-10/
https://www.prnewswire.com/news-releases/fda-approves-lillys-zepbound-tirzepatide-for-chronic-weight-management-a-powerful-new-option-for-the-treatment-of-obesity-or-overweight-with-weight-related-medical-problems-301982041.html
https://www.reuters.com/business/healthcare-pharmaceuticals/uks-mhra-authorises-eli-lillys-mounjaro-2023-11-08/
https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-beats-quarterly-revenue-estimates-mounjaro-strength-2023-11-02/
https://www.ema.europa.eu/en/documents/overview/mounjaro-epar-medicine-overview_en.pdf
https://www.reuters.com/legal/eli-lilly-sues-online-pharmacies-ban-us-imports-fake-mounjaro-2023-10-19/
https://www.fiercepharma.com/pharma/eli-lilly-files-another-lawsuit-against-online-pharmacies-selling-unauthorized-versions
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-hires-cordenpharma-make-diabetes-drug-mounjaros-active-ingredient-source-2023-10-19/
https://www.prnewswire.com/news-releases/lillys-tirzepatide-shows-additional-21-1-weight-loss-after-12-weeks-of-intensive-lifestyle-intervention-for-a-total-mean-weight-loss-of-26-6-from-study-entry-over-84-weeks-301956883.html
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-warns-online-vendors-stop-selling-unapproved-weight-loss-drugs-2023-10-10/
https://endpts.com/lilly-says-about-70-of-patients-taking-tirzepatide-experienced-an-adverse-event/
https://www.reuters.com/legal/eli-lilly-sues-over-us-sales-bogus-mounjaro-weight-loss-2023-09-19/
https://www.reuters.com/breakingviews/anti-obesity-drugs-can-shrink-more-than-patients-2023-09-20/
Market Place
Share 
